Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Irritable Bowel Syndrome01:23

Irritable Bowel Syndrome

DefinitionIrritable bowel syndrome (IBS) is a functional gastrointestinal disorder characterized by recurrent combinations of abdominal pain, bloating, diarrhea, or constipation.Pathophysiology of irritable bowel syndromeIts pathophysiology is multifactorial, involving disturbances in motility, sensory processing, microbial balance, barrier integrity, and gut–brain communication. These mechanisms interact to produce symptoms that vary across IBS subtypes.Altered Motility PatternsDisordered...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Gastrointestinal Motility Disorders01:20

Gastrointestinal Motility Disorders

Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
Other Disorders of Digestive System01:30

Other Disorders of Digestive System

The gastrointestinal tract is susceptible to various disorders. If the lower esophageal sphincter is damaged, stomach acid can flow back into the esophagus, causing irritation and inflammation of the lining. This condition is called gastroesophageal reflux disease (known as heartburn) and may cause chest pain and difficulty swallowing. In the stomach, prolonged use of nonsteroidal anti-inflammatory drugs like aspirin, chronic alcohol consumption, bacterial infections such as Helicobacter...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The role of vitamin D in cardiovascular health.

Critical reviews in clinical laboratory sciences·2026
Same author

Links between personality functioning and post-traumatic stress disorder symptoms: a network analysis.

European journal of psychotraumatology·2026
Same author

Inflammatory Biomarkers and Their Associations with Arrhythmic Burden Following SGLT2-I Treatment in Chronic Heart Failure-A Subanalysis of the ERASe Trial.

Journal of clinical medicine·2026
Same author

Rethinking EEG biomarkers of brain disorders: a transdiagnostic dimensional view.

Translational psychiatry·2026
Same author

Enzymatic 2-Hydroxybutyrate Measurement for Dysglycemia Screening Beyond Conventional Fasting Measures.

Diabetes care·2026
Same author

How personality functioning shapes symptom development during and after treatment: A random intercept cross lagged panel analysis.

Comprehensive psychiatry·2026

Related Experiment Video

Updated: May 15, 2026

Demonstration of Cutaneous Allodynia in Association with Chronic Pelvic Pain
06:44

Demonstration of Cutaneous Allodynia in Association with Chronic Pelvic Pain

Published on: June 23, 2009

Non-specific, functional, and somatoform bodily complaints.

Rainer Schaefert1, Constanze Hausteiner-Wiehle, Winfried Häuser

  • 1Department of General Internal Medicine and Psychosomatics, Heidelberg University Hospital, Thibautstrasse 2, Heidelberg, Germany. Rainer.Schaefert@med.uni-heidelberg.de

Deutsches Arzteblatt International
|December 19, 2012
PubMed
Summary

Non-specific, functional, and somatoform bodily complaints affect millions, impacting quality of life. Early recognition via biopsychosocial assessment and tailored treatment, emphasizing patient cooperation, are key to effective management.

More Related Videos

In vitro Functional Characterization of Mouse Colorectal Afferent Endings
14:09

In vitro Functional Characterization of Mouse Colorectal Afferent Endings

Published on: January 21, 2015

Related Experiment Videos

Last Updated: May 15, 2026

Demonstration of Cutaneous Allodynia in Association with Chronic Pelvic Pain
06:44

Demonstration of Cutaneous Allodynia in Association with Chronic Pelvic Pain

Published on: June 23, 2009

In vitro Functional Characterization of Mouse Colorectal Afferent Endings
14:09

In vitro Functional Characterization of Mouse Colorectal Afferent Endings

Published on: January 21, 2015

Area of Science:

  • Medical Psychology
  • General Practice
  • Psychosomatic Medicine

Background:

  • Non-specific, functional, and somatoform bodily complaints are prevalent, affecting 4-10% of the general population and 20% of primary care patients.
  • These conditions often become chronic, significantly impairing quality of life and incurring high healthcare costs.
  • Inappropriate physician behavior can exacerbate these somatic complaints.

Purpose of the Study:

  • To develop an evidence-based S3 guideline for managing non-specific, functional, and somatoform bodily complaints.
  • To provide recommendations for early recognition and effective treatment strategies.
  • To improve patient outcomes and reduce healthcare costs associated with these conditions.

Main Methods:

  • Formulation of the S3 guideline by 29 medical and psychological specialty societies and a patient representative.
  • Systematic literature search analyzing over 4000 publications.
  • Two online Delphi rounds and three consensus conferences to achieve consensus.

Main Results:

  • A strong consensus was reached on most subjects, despite variable evidence quality.
  • Recommended physician approach includes therapeutic alliance, symptom/coping orientation, and avoiding stigmatizing comments.
  • Biopsychosocial diagnostic evaluation aids early recognition of complaints and comorbid conditions, reducing iatrogenic somatization.

Conclusions:

  • Thorough, simultaneous biopsychosocial diagnostic assessment is crucial for early recognition of these complaints.
  • Treatment should be tailored to the condition's severity, ranging from explanatory models and activation for mild cases to coordinated management and psychotherapy for severe cases.
  • Effective management necessitates active patient cooperation and interprofessional collaboration, coordinated by the primary care physician.